MDM-2 Oncoprotein Overexpression, p53 Gene Mutation, and VEGF Up-Regulation in Angiosarcomas
- 30 November 1998
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 153 (5), 1425-1433
- https://doi.org/10.1016/s0002-9440(10)65729-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Mutations ofp53 tumor-suppressor gene in angiosarcomaInternational Journal of Cancer, 1997
- p53 Mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposureCarcinogenesis: Integrative Cancer Research, 1995
- Anti-p53 Antibodies in Sera of Workers Occupationally Exposed to Vinyl ChlorideJNCI Journal of the National Cancer Institute, 1995
- Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1Science, 1994
- Cellular markers that distinguish the phases of hemangioma during infancy and childhood.JCI Insight, 1994
- p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workersCarcinogenesis: Integrative Cancer Research, 1994
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981